Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-12 · accession 0001835458-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-14 | 2025-11-12 | KNSA | Ragosa Mark | CFO | M - OptEx | $30.93 | +19.9K | 51.0K | +64% | +$615.5K |
| D | 2025-11-14 | 2025-11-12 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $40.94 | -19.9K | 31.1K | -39% | -$814.7K |
| D | 2025-11-14 | 2025-11-12 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -19.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-11-12 | M | A | 19,900 | $30.93 | 50,986 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-11-12 | S | D | 19,900 | $40.94 | 31,086 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $40.93 and $41.035. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2025-11-12 | M | D | 19,900 | $0.00 | 0 | D | $30.93 · — to 2028-09-19 | 19,900 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |